Reinforcement Learning based Disease Progression Model for Alzheimer's Disease
Not on the map. Why?
Abstract (arXiv)
We model Alzheimer's disease (AD) progression by combining differential equations (DEs) and reinforcement learning (RL) with domain knowledge. DEs provide relationships between some, but not all, factors relevant to AD. We assume that the missing relationships must satisfy general criteria about the working of the brain, for e.g., maximizing cognition while minimizing the cost of supporting cognition. This allows us to extract the missing relationships by using RL to optimize an objective (reward) function that captures the above criteria. We use our model consisting of DEs (as a simulator) and the trained RL agent to predict individualized 10-year AD progression using baseline (year 0) features on synthetic and real data. The model was comparable or better at predicting 10-year cognition trajectories than state-of-the-art learning-based models. Our interpretable model demonstrated, and provided insights into, "recovery/compensatory" processes that mitigate the effect of AD, even though those processes were not explicitly encoded in the model. Our framework combines DEs with RL for modelling AD progression and has broad applicability for understanding other neurological disorders.
Key facts. Cited by 10 papers in the map (data through 7 Oct 2026). Builds on 6 of its 48 references that are in the map. First posted on arXiv 30 Jun 2021.
Builds on
6 of 48 references.
References · 6
- 2017Proximal Policy Optimization Algorithmscited by 14,441
- 2015Trust Region Policy Optimizationcited by 2,503
- 2020TADPOLE Challenge: Accurate Alzheimer's disease prediction through crowdsourced forecasting of future datacited by 14
- 2018The multiphysics of prion-like diseases: progression and atrophycited by 6
- 2018Bayesian deep neural networks for low-cost neurophysiological markers of Alzheimer's disease severitycited by 6
- 2020Reinforcement Learning Framework for Deep Brain Stimulation Studycited by 6
Built on by
Citing papers per year: 2023: 4; 2024: 3; 2025: 2; 2026: 1.
10 papers.
- 2023Longformer: Longitudinal Transformer for Alzheimer's Disease Classification with Structural MRIscited by 12
- 2024Align Your Intents: Offline Imitation Learning via Optimal Transportcited by 7
- 2025Beyond Prediction: Reinforcement Learning as the Defining Leap in Healthcare AIcited by 3
- 2023Alzheimers Disease Diagnosis using Machine Learning: A Reviewcited by 1
- 2023Adaptive Aggregation for Safety-Critical Controlcited by 0
- 2023REMEDI: REinforcement learning-driven adaptive MEtabolism modeling of primary sclerosing cholangitis DIsease progressioncited by 0
- 2024Unifying Interpretability and Explainability for Alzheimer's Disease Progression Predictioncited by 0
- 2024Uncertainty Quantification in Alzheimer's Disease Progression Modelingcited by 0
- 2025LearnAD: Learning Interpretable Rules for Brain Networks in Alzheimer's Disease Classificationcited by 0
- 2026ALPACA: A Reinforcement Learning Environment for Medication Repurposing and Treatment Optimization in Alzheimer's Diseasecited by 0
- 2026ALPACA: A Reinforcement Learning Environment for Medication Repurposing and Treatment Optimization in Alzheimer's Disease22 Feb 2026
- 2025LearnAD: Learning Interpretable Rules for Brain Networks in Alzheimer's Disease Classification30 Dec 2025
- 2025Beyond Prediction: Reinforcement Learning as the Defining Leap in Healthcare AI28 Aug 2025
- 2024Uncertainty Quantification in Alzheimer's Disease Progression Modeling13 Aug 2024
- 2024Unifying Interpretability and Explainability for Alzheimer's Disease Progression Prediction11 Jun 2024
- 2024Align Your Intents: Offline Imitation Learning via Optimal Transport20 Feb 2024
- 2023REMEDI: REinforcement learning-driven adaptive MEtabolism modeling of primary sclerosing cholangitis DIsease progression2 Oct 2023
- 2023Alzheimers Disease Diagnosis using Machine Learning: A Review17 Apr 2023
- 2023Adaptive Aggregation for Safety-Critical Control7 Feb 2023
- 2023Longformer: Longitudinal Transformer for Alzheimer's Disease Classification with Structural MRIs2 Feb 2023